Evidence map›Paper›PMID 36004858›Full record

ArticleBehavioral sciences (Basel, Switzerland)2022

Effects of Ceftriaxone on Oxidative Stress and Inflammation in a Rat Model of Chronic Cerebral Hypoperfusion.

Apsorn Sattayakhom, Kosin Kalarat, Thatdao Rakmak, Sompol Tapechum, Arnaud Monteil, Chuchard Punsawad, Sarawoot Palipoch, Phanit Koomhin

Open access · goldAbstract read
In one paragraph

Article in Behavioral sciences (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. The neuroimmune-glutamate hypothesis of addiction.Neuroscience and biobehavioral reviews · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Apsorn SattayakhomSchool of Allied Health Sciences, Walailak University, Nakhonsithammarat 80160, Thailand.ORCID 0000-0003-1944-6881
Kosin KalaratSchool of Informatics, Walailak University, Nakhonsithammarat 80160, Thailand.
Thatdao RakmakSchool of Liberal Arts, Walailak University, Nakhonsithammarat 80160, Thailand.
Sompol TapechumDepartment of Physiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.
Arnaud MonteilInstitutde Génomique Fonctionnelle, University of Montpellier, CNRS, INSERM, 34094 Montpellier, France.
Chuchard PunsawadSchool of Medicine, Walailak University, Nakhonsithammarat 80160, Thailand.ORCID 0000-0003-4826-9474
Sarawoot PalipochSchool of Medicine, Walailak University, Nakhonsithammarat 80160, Thailand.
Phanit KoomhinCenter of Excellence in Innovation on Essential Oil, Walailak University, Nakhonsithammarat 80160, Thailand.ORCID 0000-0002-1465-721X
Walailak University · THCentre National de la Recherche Scientifique · FRSiriraj Hospital · TH

Funding

Institute of Research and Development, Walailak University WU57203the government budget WU59108-2
6 · The paper itself

Abstract

Ceftriaxone (CTX) exerts a neuroprotective effect by decreasing glutamate excitotoxicity. We further studied the underlying mechanisms and effects of CTX early post-treatment on behavior in a cerebral hypoperfusion rats. The rats' common carotid arteries (2VO) were permanently ligated. CTX was treated after ischemia. Biochemical studies were performed to assess antioxidative stress and inflammation. Behavioral and histological studies were then tested on the ninth week after vessel ligation. The 2VO rats showed learning and memory deficits as well as working memory impairments without any motor weakness. The treatment with CTX was found to attenuate white matter damage, MDA production, and interleukin 1 beta and tumor necrosis factor alpha production, mainly in the hippocampal area. Moreover, CTX treatment could increase the expression of glia and the glial glutamate transporters, and the neuronal glutamate transporter. Taken together, our data indicate the neuroprotective mechanisms of CTX involving the upregulation of glutamate transporters' expression. This increased expression contributes to a reduction in glutamate excitotoxicity and oxidative stress as well as pro-inflammatory cytokine production, thus resulting in the protection of neurons and tissue from further damage. The present study highlights the mechanism of the effect of CTX treatment and of the underlying ischemia-induced neuronal damage.

Indexed as

ceftriaxoneinflammationoxidative stresswhite matter damage

Identifiers

PMID36004858
PMCPMC9404883
OpenAlexW4291415044

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.